Learn More
Medchemexpress LLC 2-((5-bromothiophen-2-yl)methyleneamino)benzamide | 304456-62-0 | MFCD00977636 | 98.0% | 309.18 g/mol | C12H9BrN2OS | 50MG

Supplier: Medchemexpress LLC HY12444750MG
BTYNB is a small-molecule inhibitor of IMP1 that disrupts IMP1 binding to c-Myc mRNA and is used in biochemical and cellular research. The compound is supplied as a white to light yellow solid with reported high purity and characterized molecular properties.
- Potent IMP1 inhibitor that disrupts IMP1-c-Myc mRNA binding (reported IC50 = 5 μM).
- High purity solid suitable for research applications (reported purity 98.0%).
- Well-characterized molecular properties (formula C12H9BrN2OS, MW 309.18 g/mol).
- Stable when stored protected from light and refrigerated as recommended.
- Intended for research use only; not for human or clinical use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.